IN2013CH01615A - - Google Patents

Download PDF

Info

Publication number
IN2013CH01615A
IN2013CH01615A IN1615CH2013A IN2013CH01615A IN 2013CH01615 A IN2013CH01615 A IN 2013CH01615A IN 1615CH2013 A IN1615CH2013 A IN 1615CH2013A IN 2013CH01615 A IN2013CH01615 A IN 2013CH01615A
Authority
IN
India
Prior art keywords
pharmaceutical composition
active agent
effective amount
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Alluri Pavan
Chandra Bose Mylamala Subhash
Prakash Uppala Susheel
Reddy Kuchanpally Santhosh
Dontika Nagaraju
Kandarapu Raghupathi
S Rudraraju Varma
Original Assignee
Aizant Drug Res Solutions Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aizant Drug Res Solutions Private Ltd filed Critical Aizant Drug Res Solutions Private Ltd
Priority to IN1615CH2013 priority Critical patent/IN2013CH01615A/en
Publication of IN2013CH01615A publication Critical patent/IN2013CH01615A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1615CH2013 2013-04-09 2013-04-09 IN2013CH01615A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1615CH2013 IN2013CH01615A (pt) 2013-04-09 2013-04-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1615CH2013 IN2013CH01615A (pt) 2013-04-09 2013-04-09

Publications (1)

Publication Number Publication Date
IN2013CH01615A true IN2013CH01615A (pt) 2015-07-03

Family

ID=54394763

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1615CH2013 IN2013CH01615A (pt) 2013-04-09 2013-04-09

Country Status (1)

Country Link
IN (1) IN2013CH01615A (pt)

Similar Documents

Publication Publication Date Title
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
MX365939B (es) Moduladores del transporte nuclear y usos de los mismos.
PH12015501096A1 (en) Composition for immediate and extended release
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
MA44637A1 (fr) Composes hétérocycliques et leurs utilisations
EA201500742A1 (ru) Защищенные от нецелевого использования фармацевтические композиции
TR201909447T4 (tr) Aramkol tuzları.
MY169099A (en) Injectable formulation
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2014153009A3 (en) Thiosaccharide mucolytic agents
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
CL2016001094A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
MX2015005762A (es) Producto de comicronizacion que comprende acetato de ulipristal.
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
CY1122538T1 (el) Συμπλεγματα χονδροϊτινης για διαδερμικη απορροφηση
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
IN2013CH01615A (pt)
LV15003A (lv) Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
EA201491477A1 (ru) Фармацевтические составы, содержащие флупиртин